Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: efood125, Hunchbackgeek, mind1, $Pistol Pete$, fraum, Pmcbinv
Search This Board: 
Last Post: 10/22/2019 3:26:33 AM - Followers: 810 - Board type: Free - Posts Today: 4

Welcome to PharmaCyte BioTech
An OTCQB Company

http://pharmacyte.com/  

 
 
 
 
 

 

 




 
 
 
 




PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.
 

 

FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$43,822,162 a/o August 14,2019

Shares Outstanding:
1, 217,282,283 a/o July 26,2019

Authorized Shares:
1,490,000,000 a/o July 26, 2019

Float:
1,079,454,505 a/o Feb. 21, 2019


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:

American Stock Transfer & Trust Company

Investor Relations

Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Current Report Filing (8-k) 10/03/2019 04:02:12 PM
PMCB News: Top 4 Penny Stocks to Watch This Week 09/16/2019 12:35:00 PM
PMCB News: Quarterly Report (10-q) 09/13/2019 05:17:12 PM
PMCB News: Current Report Filing (8-k) 08/26/2019 08:01:04 AM
PMCB News: Annual Report (10-k) 08/13/2019 06:03:31 AM
PostSubject
#102214  Sticky Note $PMCB Shareholder Update on our clinical trial product $Pistol Pete$ 09/20/19 10:46:29 PM
#100960  Sticky Note $PMCB PharmaCyte Biotech Releases New Video Documentary $Pistol Pete$ 09/10/19 09:03:07 PM
#104762   I agree. Very poor communication. 1234jklm 10/22/19 03:26:33 AM
#104761   Considering he has been telling us for years Redoocs 10/22/19 12:28:31 AM
#104760   Does anyone know if ryangroup are still investing 1234jklm 10/22/19 12:20:31 AM
#104759   Who says this has been dragged out? 1234jklm 10/22/19 12:13:43 AM
#104758   I'd rather have Matlock over Uncle Kenny any day. Redoocs 10/21/19 11:43:21 PM
#104757   Staggered run results due and once they are Jimmy Joe 10/21/19 11:37:53 PM
#104756   We are all so worn down by the 1234jklm 10/21/19 11:08:46 PM
#104755   It works and sigilon just sold theirs for 1234jklm 10/21/19 11:06:04 PM
#104754   No one knows about this yet. 1234jklm 10/21/19 11:02:16 PM
#104753   But there is no future in the past Jimmy Joe 10/21/19 11:00:18 PM
#104752   Microencapsulation is for real people. It works. Jimmy Joe 10/21/19 10:57:15 PM
#104751   but Uncle Kenny years of being a penny Jimmy Joe 10/21/19 10:56:16 PM
#104749   LOL~! This is the OTCbb, the market knows Jimmy Joe 10/21/19 10:48:29 PM
#104748   Understand why investors who bought in 2007 feel upset. 1234jklm 10/21/19 08:47:08 PM
#104746   yes efood,keep the faith,the story of pmcb is livendi 10/21/19 08:04:27 PM
#104743   Yeah...yeah...yeah...but IND is about to be filed...then acceptance...then efood125 10/21/19 05:51:11 PM
#104732   but Uncle Kenny years of being a penny thenewmixer 10/21/19 05:06:18 PM
#104731   just think about it pmcb tells you how thenewmixer 10/21/19 04:56:46 PM
#104730   PMCB going to save lives over 20 years thenewmixer 10/21/19 04:54:01 PM
#104727   It shows how long the CIAB Scam has bearspread 10/21/19 04:15:59 PM
#104725   Austrianova is currently commissioning a GMP manufacturing facility bearspread 10/21/19 03:33:38 PM
#104724   This one smells Pharmacyte + AN to me... ThermoFisher Turning JODI1 10/21/19 03:08:59 PM
#104723   And unfortunately that brings me back to my Redoocs 10/21/19 03:05:24 PM
#104722   Esusun...and just to think cell in box is efood125 10/21/19 03:00:01 PM
#104720   well , we will need to get esusun 10/21/19 02:52:09 PM
#104719   Got it. Thanks for clarifying. Redoocs 10/21/19 02:50:42 PM
#104718   It shows how long the CIAB Scam has concordia 10/21/19 02:42:46 PM
#104717   this shows history of development and $$$ invested esusun 10/21/19 02:31:22 PM
#104716   hey efood , well i know you esusun 10/21/19 02:22:56 PM
#104715   No panic selling...watch out for good news...don't let efood125 10/21/19 02:07:24 PM
#104714   They show the continued failures of pmcb and company thenewmixer 10/21/19 01:52:42 PM
#104713   Why are 10/12 year old press releases relevant? Redoocs 10/21/19 01:35:49 PM
#104712   Good stuff as usual esusun.... efood125 10/21/19 01:35:40 PM
#104711   Go for it Pmcb livendi 10/21/19 01:03:44 PM
#104710   THIS TIME PMCB + AN WILL GET IT esusun 10/21/19 12:59:54 PM
#104709   wow was going to listen to CC again thenewmixer 10/21/19 12:48:53 PM
#104708   Ask them. bearspread 10/21/19 11:25:28 AM
#104707   After 3 decades of work how could anyone 1234jklm 10/21/19 11:06:11 AM
#104706   do some searching Bearspread , I am sure bearspread 10/21/19 10:56:19 AM
#104705   Wouldn't it be a kick in the head bearspread 10/21/19 10:42:27 AM
#104704   you are welcome 1234 esusun 10/21/19 10:40:50 AM
#104703   I would love to see Gunzburg and Salmons esusun 10/21/19 10:39:16 AM
#104702   do some searching Bearspread , I am esusun 10/21/19 10:37:40 AM
#104701   They have certainly achieved an enormous amount 1234jklm 10/21/19 10:18:25 AM
#104700   if you are gonna keep bringing this bearspread 10/21/19 10:13:09 AM
#104699   "The most important event left to complete outside tulla236a 10/21/19 10:10:55 AM
#104698   Thank you for pointing out that the past itzgood 10/21/19 09:55:37 AM
#104697   We will see if they have the money mind1 10/21/19 09:47:44 AM
#104696   Possible good news this week. Redoocs 10/21/19 09:41:24 AM
#104695   Great information. Thankyou. 1234jklm 10/21/19 09:39:23 AM
PostSubject